Nifty

:

8083.80

Sensex

:

27590.95

-170.00 (-2.06%)
-674.36 (-2.39%)

Login

Nifty
Sensex

:
:

8083.80
27590.95

-170.00 (-2.06%)
-674.36 (-2.39%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

83/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

1224.20

03-Apr-2020

Open
High
Low
Previous Close

1230.00
1248.00
1155.00
1210.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

64230
763.01
1748.00
962.65

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

20,718.36
262.62
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

19,547.60
1.64%
12.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-1.44
2.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
0.90
7.47

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-1.34
9.76

P:E (Median)

8 Years
5 Years
3 Years

57.58
61.55
61.98

P:BV (Average)

8 Years
5 Years
3 Years

11.89
12.74
11.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

32.15
37.93
37.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 778.68 825.35 -5.65% 882.10 816.31 8.06% 788.02 735.65 7.12% 751.22 748.62 0.35%
Expenses 654.03 688.03 -4.94% 687.86 651.15 5.64% 622.54 595.28 4.58% 587.59 593.76 -1.04%
EBITDA 124.65 137.32 -9.23% 194.24 165.16 17.61% 165.48 140.37 17.89% 163.63 154.86 5.66%
EBIDTM 16.01% 16.64% 22.02% 20.23% 21.00% 19.08% 21.78% 20.69%
Other Income 16.25 16.42 -1.04% 15.61 14.82 5.33% 30.54 17.78 71.77% 52.46 18.15 189.04%
Interest 2.98 0.05 5,860.00% 0.92 0.22 318.18% 0.93 0.20 365.00% 0.08 0.04 100.00%
Depreciation 18.33 12.04 52.24% 22.70 11.51 97.22% 19.06 11.36 67.78% 13.68 9.36 46.15%
PBT -617.31 169.78 - 587.37 156.46 275.41% 176.03 138.31 27.27% 199.16 163.61 21.73%
Tax 26.83 56.81 -52.77% 84.58 55.69 51.88% 62.57 49.72 25.84% 76.13 58.06 31.12%
PAT -644.14 112.97 - 502.79 100.77 398.95% 113.46 88.59 28.07% 123.03 105.55 16.56%
PATM -82.72% 13.69% 57.00% 12.34% 14.40% 12.04% 16.38% 14.10%
EPS -38.02 6.67 - 29.68 5.95 398.82% 6.70 5.23 28.11% 7.26 6.23 16.53%

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 778.59 825.35 -5.67% 882.02 0.00 0 787.97 0.00 0 751.13 0.00 0
Expenses 654.20 688.20 -4.94% 688.01 0.00 0 622.68 0.00 0 588.08 0.00 0
EBITDA 124.39 137.15 -9.30% 194.01 0.00 0 165.29 0.00 0 163.05 0.00 0
EBIDTM 15.98% 16.62% 22.00% 0.00% 20.98% 0.00% 21.71% 0.00%
Other Income 16.50 16.58 -0.48% 15.88 0.00 0 30.81 0.00 0 52.72 0.00 0
Interest 2.98 0.05 5,860.00% 0.92 0.00 0 0.93 0.00 0 0.08 0.00 0
Depreciation 18.33 12.04 52.24% 22.70 0.00 0 19.06 0.00 0 13.68 0.00 0
PBT -634.32 170.48 - 587.41 0.00 0 176.11 0.00 0 198.82 0.00 0
Tax 26.84 56.81 -52.75% 84.66 0.00 0 62.57 0.00 0 75.06 0.00 0
PAT -661.16 113.67 - 502.75 0.00 0 113.54 0.00 0 123.76 0.00 0
PATM -84.92% 13.77% 57.00% 0.00% 14.41% 0.00% 16.48% 0.00%
EPS -39.03 6.71 - 29.68 0.00 0 6.70 0.00 0 7.31 0.00 0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Net Sales 3,200.02 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 2,591.16 2,671.83 2,416.86 2,111.64 1,870.77 Net Sales Growth 2.37% 8.94% -1.08% 2.72% -15.53% 29.13% -3.02% 10.55% 14.45% 12.88% Cost Of Goods Sold 1,333.50 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 1,166.02 1,094.24 912.83 774.61 690.35 Gross Profit 1,866.52 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 1,425.14 1,577.58 1,504.03 1,337.03 1,180.42 GP Margin 58.33% 56.74% 56.79% 51.99% 53.34% 60.46% 55.00% 59.04% 62.23% 63.32% 63.10% Total Expenditure 2,552.02 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 2,114.09 1,901.95 1,675.46 1,459.69 1,307.15 Power & Fuel Cost - 27.94 26.44 27.82 25.97 31.17 23.85 22.50 26.70 26.75 24.66 % Of Sales - 0.89% 0.92% 0.96% 0.92% 0.93% 0.92% 0.84% 1.10% 1.27% 1.32% Employee Cost - 537.20 523.40 483.01 443.37 493.02 362.05 295.52 278.36 234.53 203.97 % Of Sales - 17.17% 18.23% 16.64% 15.69% 14.73% 13.97% 11.06% 11.52% 11.11% 10.90% Manufacturing Exp. - 115.19 110.55 108.26 117.67 365.85 127.72 113.57 111.16 67.08 59.67 % Of Sales - 3.68% 3.85% 3.73% 4.16% 10.93% 4.93% 4.25% 4.60% 3.18% 3.19% General & Admin Exp. - 178.51 203.43 194.72 154.34 177.98 134.79 125.55 107.78 144.41 129.42 % Of Sales - 5.71% 7.08% 6.71% 5.46% 5.32% 5.20% 4.70% 4.46% 6.84% 6.92% Selling & Distn. Exp. - 202.81 154.38 178.88 164.26 222.32 186.27 160.50 157.41 140.83 131.12 % Of Sales - 6.48% 5.38% 6.16% 5.81% 6.64% 7.19% 6.01% 6.51% 6.67% 7.01% Miscellaneous Exp. - 106.88 104.29 96.61 125.19 164.01 113.38 90.07 81.22 70.91 131.12 % Of Sales - 3.42% 3.63% 3.33% 4.43% 4.90% 4.38% 3.37% 3.36% 3.36% 3.84% EBITDA 648.00 606.48 508.44 419.94 476.75 568.79 477.07 769.88 741.40 651.95 563.62 EBITDA Margin 20.25% 19.39% 17.71% 14.47% 16.87% 17.00% 18.41% 28.81% 30.68% 30.87% 30.13% Other Income 114.86 101.48 53.52 72.01 122.25 257.53 246.31 243.07 200.93 233.56 211.60 Interest 4.91 0.55 0.19 0.25 0.42 0.47 0.33 0.33 0.33 0.62 0.37 Depreciation 73.77 48.59 37.99 26.35 24.95 25.35 19.88 17.84 20.41 17.63 16.37 PBT 345.25 658.82 523.78 465.35 573.63 800.50 703.17 994.78 921.60 867.27 758.48 Tax 250.11 238.35 189.60 174.30 201.41 276.98 227.44 269.30 168.45 285.88 253.59 Tax Rate 72.44% 35.91% 35.01% 34.10% 34.97% 37.00% 31.19% 31.81% 28.12% 32.96% 33.43% PAT 95.14 425.36 351.99 336.78 374.53 471.65 501.88 577.26 430.60 581.38 504.89 PAT before Minority Interest 95.14 425.36 351.99 336.78 374.53 471.65 501.88 577.26 430.60 581.38 504.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.97% 13.60% 12.26% 11.60% 13.25% 14.10% 19.37% 21.61% 17.82% 27.53% 26.99% PAT Growth -76.67% 20.84% 4.52% -10.08% -20.59% -6.02% -13.06% 34.06% -25.93% 15.15% Unadjusted EPS 5.62 25.11 20.78 39.76 44.22 55.68 59.25 68.15 50.84 66.55 60.48

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Net Sales 3,199.71 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 2,607.70 2,692.06 2,455.38 2,151.06 1,907.77 Net Sales Growth 287.68% 8.94% -1.27% 2.49% -15.61% 28.96% -3.13% 9.64% 14.15% 12.75% Cost Of Goods Sold 1,333.50 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 1,171.68 1,100.57 923.50 785.73 700.01 Gross Profit 1,866.21 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 1,436.02 1,591.49 1,531.87 1,365.33 1,207.75 GP Margin 58.32% 56.59% 56.77% 51.94% 53.31% 60.52% 55.07% 59.12% 62.39% 63.47% 63.31% Total Expenditure 2,552.97 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 2,124.49 1,915.22 1,693.90 1,478.25 1,324.67 Power & Fuel Cost - 27.94 26.44 27.82 25.97 31.17 23.85 22.50 26.70 26.75 24.66 % Of Sales - 0.89% 0.92% 0.96% 0.92% 0.93% 0.91% 0.84% 1.09% 1.24% 1.29% Employee Cost - 537.20 523.40 483.01 443.37 493.02 362.05 295.52 278.36 234.53 203.97 % Of Sales - 17.17% 18.23% 16.61% 15.62% 14.66% 13.88% 10.98% 11.34% 10.90% 10.69% Manufacturing Exp. - 115.55 110.55 108.26 118.09 367.24 127.78 113.62 111.44 67.51 60.08 % Of Sales - 3.69% 3.85% 3.72% 4.16% 10.92% 4.90% 4.22% 4.54% 3.14% 3.15% General & Admin Exp. - 178.60 204.45 195.08 154.85 178.21 135.34 126.10 108.51 145.09 130.13 % Of Sales - 5.71% 7.12% 6.71% 5.46% 5.30% 5.19% 4.68% 4.42% 6.75% 6.82% Selling & Distn. Exp. - 202.81 154.38 178.91 164.47 222.31 186.23 160.74 157.60 140.85 131.33 % Of Sales - 6.48% 5.38% 6.15% 5.80% 6.61% 7.14% 5.97% 6.42% 6.55% 6.88% Miscellaneous Exp. - 107.20 105.12 98.67 127.99 168.72 117.55 96.17 87.78 72.33 131.33 % Of Sales - 3.43% 3.66% 3.39% 4.51% 5.02% 4.51% 3.57% 3.58% 3.36% 3.84% EBITDA 646.74 600.80 505.79 418.98 478.27 574.58 483.21 776.84 761.48 672.81 583.10 EBITDA Margin 20.21% 19.21% 17.61% 14.41% 16.85% 17.09% 18.53% 28.86% 31.01% 31.28% 30.56% Other Income 115.91 102.32 54.54 73.07 123.18 258.80 222.30 223.90 186.59 217.06 194.80 Interest 4.91 0.55 0.19 0.25 0.42 0.47 0.33 0.33 0.33 0.62 0.37 Depreciation 73.77 48.59 37.99 26.35 24.95 25.35 19.88 17.84 20.41 17.63 16.37 PBT 328.02 653.97 522.17 465.46 576.08 807.56 685.30 982.58 927.33 871.62 761.16 Tax 249.13 237.28 189.24 174.37 202.25 279.27 229.78 272.48 176.20 293.35 260.70 Tax Rate 75.95% 34.76% 35.05% 34.11% 34.97% 36.96% 32.30% 32.66% 29.13% 33.66% 34.25% PAT 78.89 445.39 350.73 336.81 376.14 476.41 481.67 561.88 428.59 578.27 500.46 PAT before Minority Interest 78.89 445.39 350.73 336.81 376.14 476.41 481.67 561.88 428.59 578.27 500.46 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.47% 14.24% 12.21% 11.58% 13.25% 14.17% 18.47% 20.87% 17.46% 26.88% 26.23% PAT Growth -30.60% 26.99% 4.13% -10.46% -21.05% -1.09% -14.28% 31.10% -25.88% 15.55% Unadjusted EPS 4.66 26.29 20.70 39.76 44.41 56.24 56.87 66.34 50.60 66.18 59.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Shareholder's Funds 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 2,017.19 2,010.02 1,919.93 1,930.81 1,759.15 Share Capital 169.41 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 1,932.49 1,925.31 1,835.23 1,846.11 1,674.45 Non-Current Liabilities 2,835.06 2,572.79 3,639.66 190.35 195.96 157.51 157.36 171.68 -51.23 -39.27 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.18 0.58 0.99 1.60 2.63 3.61 4.14 4.59 5.16 5.42 Long Term Provisions 2,893.17 2,673.01 3,726.49 283.90 270.96 241.04 234.79 223.56 0.00 0.00 Current Liabilities 2,800.62 2,945.16 878.32 574.86 1,105.86 883.07 835.75 857.98 3,120.66 2,668.86 Trade Payables 402.96 502.53 275.92 323.09 305.89 278.01 235.19 198.34 331.92 291.38 Other Current Liabilities 802.59 842.33 391.18 203.59 131.56 86.22 88.35 68.37 14.30 25.29 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 1,595.07 1,600.30 211.22 48.18 668.42 518.83 512.21 591.28 2,774.44 2,352.19 Total Liabilities 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 3,057.77 3,003.13 2,949.59 5,000.24 4,388.74 Net Block 429.99 322.81 252.71 204.04 123.06 100.07 89.40 99.13 108.93 92.81 Gross Block 559.05 405.89 299.09 228.36 319.19 299.08 272.04 271.66 318.40 289.18 Accumulated Depreciation 129.06 83.08 46.38 24.32 196.13 199.01 182.63 172.53 209.47 196.37 Non Current Assets 4,437.17 4,085.73 4,735.48 822.06 588.30 456.03 390.73 380.12 278.01 305.08 Capital Work in Progress 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 16.19 8.72 21.36 Non Current Investment 26.17 49.43 52.99 53.63 47.67 47.67 57.68 102.59 160.35 190.91 Long Term Loans & Adv. 2,970.52 2,785.85 3,817.84 296.66 291.23 232.87 189.69 152.93 0.00 0.00 Other Non Current Assets 7.84 4.75 6.47 0.06 11.12 13.55 10.18 9.27 0.00 0.00 Current Assets 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 2,601.73 2,612.40 2,569.48 4,722.23 4,083.66 Current Investments 0.00 0.00 0.00 0.00 0.00 10.00 44.91 57.21 0.00 0.00 Inventories 486.49 500.18 425.48 521.66 368.86 342.40 282.04 330.14 281.54 253.02 Sundry Debtors 120.49 146.96 170.80 126.56 100.32 96.39 115.90 85.31 47.03 53.73 Cash & Bank 1,155.33 1,279.69 882.23 1,377.68 1,898.02 2,027.14 2,038.78 1,984.09 1,948.08 1,672.60 Other Current Assets 1,578.61 78.51 105.92 23.24 197.99 125.80 130.77 112.73 2,445.59 2,104.30 Short Term Loans & Adv. 1,466.65 1,506.82 226.27 98.66 109.61 68.16 55.79 49.40 2,392.77 2,074.77 Net Current Assets 540.31 567.01 932.39 1,572.94 1,459.32 1,718.67 1,776.65 1,711.50 1,601.57 1,414.80 Total Assets 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48 3,057.76 3,003.13 2,949.60 5,000.24 4,388.74

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Shareholder's Funds 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 1,989.73 2,006.83 1,935.70 1,951.58 1,786.09 Share Capital 169.41 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 1,905.03 1,922.13 1,851.00 1,866.88 1,701.39 Non-Current Liabilities 2,860.37 2,632.47 3,699.70 3,498.32 197.04 158.59 158.45 172.78 -51.43 -39.47 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.18 0.58 0.99 1.60 2.63 3.61 4.14 4.59 5.16 5.42 Long Term Provisions 2,920.20 2,733.36 3,786.83 3,592.19 272.21 242.29 236.05 224.81 0.00 0.00 Current Liabilities 2,804.07 2,948.98 881.09 783.63 1,106.55 888.91 836.40 859.59 3,179.07 2,718.89 Trade Payables 405.81 505.86 278.93 327.74 308.04 285.63 237.37 200.58 334.36 294.42 Other Current Liabilities 802.71 842.35 390.47 202.82 130.09 84.13 86.82 67.25 12.60 22.78 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 1,595.54 1,600.77 211.69 253.08 668.42 519.15 512.21 591.77 2,832.12 2,401.69 Total Liabilities 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 3,037.23 3,001.68 2,968.07 5,079.22 4,465.51 Net Block 429.99 322.81 252.71 204.04 123.08 100.09 89.42 99.15 108.95 92.83 Gross Block 559.05 405.89 299.09 228.36 363.34 343.22 316.18 315.80 362.54 333.32 Accumulated Depreciation 129.06 83.08 46.38 24.32 240.26 243.13 226.76 216.65 253.59 240.49 Non Current Assets 4,445.06 4,103.26 4,752.54 4,087.05 545.58 413.30 355.01 363.01 235.57 262.64 Capital Work in Progress 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 16.19 8.72 21.36 Non Current Investment 1.69 1.84 5.40 6.04 0.06 0.06 10.06 54.98 117.90 148.46 Long Term Loans & Adv. 3,002.88 2,850.97 3,882.49 3,609.24 296.09 237.73 194.55 157.01 0.00 0.00 Other Non Current Assets 7.84 4.75 6.47 0.06 11.13 13.55 17.19 35.68 0.00 0.00 Current Assets 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 2,623.94 2,646.67 2,605.06 4,843.65 4,202.88 Current Investments 0.00 0.00 0.00 0.00 0.00 10.00 44.91 57.21 0.00 0.00 Inventories 486.49 500.18 425.80 525.87 375.58 346.97 285.15 333.44 285.55 257.30 Sundry Debtors 120.49 146.96 170.80 126.56 100.32 96.39 115.90 85.31 47.03 53.73 Cash & Bank 1,171.35 1,296.41 899.61 1,391.90 1,910.61 2,041.58 2,066.77 2,014.36 2,002.89 1,733.90 Other Current Assets 1,580.88 78.72 106.70 23.24 200.47 128.99 133.94 114.74 2,508.18 2,157.95 Short Term Loans & Adv. 1,468.58 1,513.25 232.20 310.58 112.04 71.19 58.18 50.12 2,454.34 2,127.55 Net Current Assets 555.14 586.54 954.01 1,594.52 1,480.43 1,735.03 1,810.27 1,745.46 1,664.58 1,483.98 Total Assets 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56 3,037.24 3,001.68 2,968.07 5,079.22 4,465.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Cash From Operating Activity 401.07 474.77 232.28 138.27 340.88 267.42 293.63 321.56 467.55 503.30 PBT 658.82 523.78 465.35 573.63 800.50 703.17 994.78 921.60 867.27 758.48 Adjustment -30.52 -11.15 -45.42 -95.08 -172.39 -180.38 -178.80 -153.72 -105.04 -85.01 Changes in Working Capital -7.58 163.69 -29.47 -125.04 -30.17 1.66 38.79 -74.06 11.06 22.22 Cash after chg. in Working capital 620.71 676.33 390.46 353.51 597.94 524.44 854.76 693.82 773.29 695.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -204.26 -201.82 -160.86 -204.42 -250.13 -242.05 -313.81 -309.30 -304.67 -177.43 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -15.38 0.25 2.67 -10.82 -6.93 -14.97 -247.33 -62.96 -1.06 -14.97 Cash From Investing Activity -144.33 -107.01 303.08 499.09 177.62 197.98 -92.58 368.48 101.99 654.82 Net Fixed Assets -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 39.27 -16.58 -18.44 Net Investments 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 0.55 30.56 560.97 Others 65.31 313.67 710.96 566.67 241.09 198.17 -121.81 328.66 88.01 112.29 Cash from Financing Activity -358.36 -306.63 -510.76 -638.33 -496.99 -490.08 -437.07 -391.82 -294.09 -391.77 Net Cash Inflow / Outflow -101.62 61.12 24.59 -0.98 21.51 -24.68 -236.01 298.22 275.46 766.35 Opening Cash & Equivalents 199.40 138.27 113.68 114.66 93.50 137.07 373.08 74.86 1,672.73 906.39 Closing Cash & Equivalent 97.78 199.40 138.27 113.68 115.01 112.39 137.07 373.08 1,948.19 1,672.73

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Cash From Operating Activity 399.38 472.80 234.37 138.90 337.64 281.31 313.59 335.37 479.36 511.51 PBT 653.97 522.17 465.46 576.08 807.56 685.30 982.58 927.33 871.62 761.16 Adjustment -31.36 -12.17 -46.47 -96.01 -173.66 -156.37 -159.63 -139.38 -89.96 -69.78 Changes in Working Capital -4.19 164.56 -26.69 -124.41 -36.90 11.45 56.35 -73.09 12.66 20.47 Cash after chg. in Working capital 618.41 674.55 392.29 355.67 597.00 540.37 879.30 714.86 794.32 711.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -204.34 -202.01 -160.59 -205.95 -252.43 -244.09 -318.38 -316.53 -313.89 -185.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -14.69 0.25 2.67 -10.82 -6.93 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -143.34 -104.19 300.64 499.02 180.01 188.98 -109.65 358.03 86.76 660.78 Net Fixed Assets -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 39.27 -16.58 -18.44 Net Investments 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 0.55 30.56 560.97 Others 66.30 316.49 708.52 566.60 243.48 189.17 -138.88 318.21 72.78 118.25 Cash from Financing Activity -358.36 -306.63 -510.76 -638.33 -496.99 -494.14 -440.63 -394.81 -297.15 -394.84 Net Cash Inflow / Outflow -102.33 61.97 24.24 -0.42 20.66 -23.85 -236.69 298.59 268.97 777.45 Opening Cash & Equivalents 201.10 139.13 114.89 115.30 94.93 137.67 374.36 75.77 1,734.03 956.58 Closing Cash & Equivalent 98.78 201.10 139.13 114.89 115.59 113.82 137.67 374.36 2,003.01 1,734.03

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Book Value (Rs.) 126.47 122.78 119.72 130.14 109.30 119.07 118.65 113.33 113.98 103.84 ROA 5.53% 4.98% 7.08% 12.23% 15.19% 16.56% 19.39% 10.83% 12.38% 12.07% ROE 20.15% 17.14% 15.91% 18.47% 24.38% 24.92% 29.38% 22.36% 31.51% 30.60% ROCE 31.45% 26.36% 24.14% 28.38% 38.65% 36.16% 43.00% 31.05% 46.91% 45.83% Fixed Asset Turnover 6.48 8.22 11.35 10.32 11.16 9.33 10.09 8.37 7.09 6.70 Receivable days 15.60 20.03 18.12 14.65 10.40 14.54 13.39 9.78 8.53 10.66 Inventory Days 57.56 58.34 57.72 57.50 37.61 42.77 40.75 45.18 45.27 45.93 Payable days 72.90 65.55 50.91 53.40 43.13 48.42 47.09 62.05 88.60 85.17 Cash Conversion Cycle 0.26 12.81 24.94 18.76 4.88 8.89 7.05 -7.09 -34.80 -28.58 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 1198.38 2865.01 2045.32 1368.05 1597.21 2205.05 2534.09 1830.74 1396.44 2073.36

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Book Value (Rs.) 126.31 121.44 118.46 128.88 107.96 117.45 118.46 114.26 115.20 105.43 ROA 5.77% 4.93% 5.16% 7.84% 15.44% 15.95% 18.82% 10.65% 12.12% 11.74% ROE 21.22% 17.26% 16.08% 18.75% 24.95% 24.10% 28.50% 22.05% 30.94% 29.77% ROCE 32.54% 26.56% 24.39% 28.82% 39.53% 35.54% 42.24% 31.05% 46.54% 45.16% Fixed Asset Turnover 6.48 8.21 11.38 9.59 9.82 8.13 8.74 7.40 6.31 5.91 Receivable days 15.60 20.03 18.09 14.59 10.35 14.45 13.29 9.62 8.38 10.45 Inventory Days 57.56 58.36 57.89 57.97 38.01 43.02 40.86 45.01 45.13 45.88 Payable days 73.24 66.07 51.56 53.81 43.72 49.18 47.40 62.14 88.58 85.41 Cash Conversion Cycle -0.07 12.32 24.42 18.75 4.64 8.28 6.75 -7.51 -35.07 -29.09 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 1232.59 2856.45 2045.74 1373.88 1612.26 2146.51 2497.59 1848.25 1403.44 2037.83

Top Investors:

lici new endowment plus-balanced fund

aditya birla sun life trustee private limited a/c aditya birla sun life tax relief 96

general insurance corporation of india

qualified institutional buyer

Annual Reports:

News Update:

Glaxosmithkline Pharmaceuticals reports consolidated net loss of Rs 661 crore in Q3
4th Feb 2020, 10:08 AM

Total consolidated income of the company decreased by 5.56% at Rs 795.09 crore for Q3FY20
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback